Y, M., MM, M., Z, G., M, R., L, M., & GD, P. (2023). Intravitreal Fluocinolone Acetonide Implant (ILUVIEN®) for the Treatment of Retinal Conditions. A Review of Clinical Studies. Drug Design, Development and Therapy, ume 17, 961-975.
Chicago-referens (17:e uppl.)Y, Mushtaq, Mushtaq MM, Gatzioufas Z, Ripa M, Motta L, och Panos GD. "Intravitreal Fluocinolone Acetonide Implant (ILUVIEN®) for the Treatment of Retinal Conditions. A Review of Clinical Studies." Drug Design, Development and Therapy ume 17 (2023): 961-975.
MLA-referens (9:e uppl.)Y, Mushtaq, et al. "Intravitreal Fluocinolone Acetonide Implant (ILUVIEN®) for the Treatment of Retinal Conditions. A Review of Clinical Studies." Drug Design, Development and Therapy, vol. ume 17, 2023, pp. 961-975.